<DOC>
	<DOCNO>NCT00354133</DOCNO>
	<brief_summary>Parkinsons ' disease one disabling chronic neurological disease . It treat sufficiently motor complication fluctuation mobility dyskinesias develop . The quality life social occupational functioning relentlessly deteriorate longer disease duration complication conservative therapy develop . High-frequency stimulation subthalamic nucleus especially improve motor complication Parkinson 's disease preliminary data suggest also quality life psychosocial handicap improve . So far therapy used patient already undergone personal , professional social degradation due motor complication disease . The aim study ass use therapy earlier stage disease , motor complication develop patient significantly affect social occupational functioning .</brief_summary>
	<brief_title>Controlled Trial Deep Brain Stimulation Early Patients With Parkinson 's Disease</brief_title>
	<detailed_description>Patients randomize either medical treatment subthalamic stimulation . The observation period 2 year . The primary outcome criterium : PDQ-39 .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Idiopathic Parkinson 's Disease Hoehn Yahr stage ≤ 2.5 best `` '' med condition Disease duration &gt; 4 year Presence fluctuation and/or dyskinesias 3 year One two follow form impairment : Impairment activity daily live ( UPDRS II &gt; 6 ) due PDsymptoms despite medical treatment `` bad '' condition Impairment social occupational functioning ( measure modify SOFAS ) due PDsymptoms despite medical treatment ( 5180 % ) PDQ39 complete Written inform consent For patient France social security number require Exclusion Criteria Major depression suicidal thought ( Beck Depression Inventory &gt; 25 ) Dementia ( Mattis Score ≤ 130 ) Acute psychosis Need nursing care Any medical psychological problem may interfere smooth conduction study protocol ( e.g . cancer limit life expectancy ) Drug alcohol addiction Surgical contraindication Fertile woman use adequate contraceptive method Women pregnant breast feed Illiteracy insufficient language skill ( German French ) complete questionnaire Simultaneous participation another clinical trial except trial affect Earlystim study approve documented steer committee</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Parkinson Disease</keyword>
	<keyword>Deep Brain Stimulation</keyword>
	<keyword>PDQ-39</keyword>
</DOC>